Tomorrow Investor

Colgate-Palmolive Q3 Sales Rise 1.9% as Pricing Gains Offset Volume Decline

fileName-colgate-palmolive-q3-sales-rise-1-9-as-pricing-gains-offset-volume-decline-1761915860416
fileName-colgate-palmolive-q3-sales-rise-1-9-as-pricing-gains-offset-volume-decline-1761915860416

NEW YORK, Oct 31, 2025 – Colgate-Palmolive (CL) reported third-quarter sales growth of 1.9% to 5.13 billion as higher prices offset a 1.9% volume decline, meeting Wall Street expectations.

The consumer goods giant’s ability to maintain revenue growth despite lower unit sales demonstrates the effectiveness of its pricing strategy amid ongoing inflationary pressures.

Key Takeaways

  • Q3 sales rose 1.9% to 5.13 billion, meeting analyst forecasts
  • Pricing gains of 2.3% offset 1.9% volume decline
  • Organic sales growth of 0.4% shows underlying business resilience

Market Reaction & Context

Colgate’s third-quarter performance reflects broader trends across consumer staples companies, which have relied heavily on price increases to counter rising input costs and maintain margins. The company’s organic sales growth of 0.4% compares favorably to many peers in the household products sector that have struggled with volume declines 1.

Total sales reached 5.13 billion, in line with Wall Street models, while organic sales edged 0.4% higher during the quarter 2.

Detailed Analysis

The company’s pricing strategy proved effective in Q3, with a 2.3% increase in pricing more than offsetting the 1.5% decline in volume, according to recent reports 3. This pricing power demonstrates Colgate’s strong brand positioning in oral care and personal care categories.

The volume decline of 1.9% year-over-year marked a reversal from the company’s historical performance levels, suggesting consumers are becoming more price-sensitive 1. However, management’s ability to maintain revenue growth through strategic pricing indicates the strength of Colgate’s market position.

Segment Performance

Hill’s U.S. division showed resilience with low single-digit organic sales growth, achieving roughly flat volume alongside positive pricing during the quarter 4. The pet nutrition segment continues to be a bright spot for the company’s portfolio.

Volume growth in some segments was negatively impacted by broader market conditions, but pricing actions helped offset these headwinds across most business units 4.

Management Outlook

Chief Executive Noel Wallace has emphasized the company’s focus on balancing volume and pricing to drive sustainable growth 2. The company’s strategic approach to pricing reflects management’s confidence in brand strength and market positioning.

Earlier analyst predictions suggested pricing gains of 2.2% would largely offset an expected volume decline of 0.1% for the third quarter, with models predicting a 1.5% rise in overall sales 5.

Investment Implications

Colgate-Palmolive’s stock has declined nearly 20% over the past year, raising questions about market expectations relative to the company’s operational performance 6. The Q3 results suggest the company’s fundamental business remains resilient despite challenging market conditions.

The company’s ability to maintain sales growth through pricing actions while managing volume pressures positions it well for continued navigation of the current inflationary environment.

Not investment advice. For informational purposes only.

References

1“Colgate-Palmolive (NYSE:CL) Reports Q3 In Line With Expectations”. Finviz. Retrieved Oct 31, 2025.

2“Colgate-Palmolive 3Q Sales Rise as Higher Prices Offset Lower”. Futu News. Retrieved Oct 31, 2025.

3“Colgate-Palmolive’s Q3 2023 Dilemma: Why Rising Sales Haven’t Boosted Earnings”. Ainvest. Retrieved Oct 31, 2025.

4“Colgate Palmolive: 3Q 2025 Prepared Management Remarks”. MarketScreener. Retrieved Oct 31, 2025.

5“Colgate’s Pre-Q3 Earnings: Will Pricing Actions Offset Cost Headwinds”. Nasdaq. Retrieved Oct 31, 2025.

6“Colgate-Palmolive: 2 Reasons Why The Share Price Drop Has Gone Too Far”. Seeking Alpha. Retrieved Oct 31, 2025.